GlobalData on MSN22h
EMA’s CHMP recommends Sanofi’s Sarclisa approval for multiple myeloma
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...
pharmaphorum7d
FDA sets date for Sarclisa in first-line multiple myeloma
The French pharma group has filed anti-CD38 antibody Sarclisa (isatuximab) for use in combination with Takeda’s Velcade (bortezomib), lenalidomide, and dexamethasone – known as the VRd regimen ...
Zacks.com on MSN1mon
Sanofi's Sarclisa Gets FDA Nod for Expanded Use in Multiple Myeloma
With this nod, Sarclisa is now approved in combination with Velcade (bortezomib), Bristol Myers’ BMY Revlimid (lenalidomide) ...